Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes

This publication has 16 references indexed in Scilit:

• Is apoptosis a massive process in myelodysplastic syndromes?
  British Journal of Haematology, 1996
• Bone marrow histology and CD34 immunostaining in the prognostic evaluation of primary myelodysplastic syndromes
  British Journal of Haematology, 1996
• Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis
  American Journal of Hematology, 1995
• Advances and controversies in the study of programmed cell death/apoptosis in the development of and therapy for cancer
  Current Opinion in Oncology, 1994
• A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA.
  Journal of Histochemistry & Cytochemistry, 1993
• Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
  The Journal of cell biology, 1992
• The Origins of DNA Breaks: A Consequence of DNA Damage, DNA Repair, or Apoptosis?
  Cancer Investigation, 1992
• The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin
  British Journal of Haematology, 1991
• Modifications in the classification of primary myelodysplastic syndromes: The addition of a scoring system
  Hematological Oncology, 1985
• Proposals for the classification of the myelodysplastic syndromes
  British Journal of Haematology, 1982